Income Statement Pfizer Inc.

Equities

PFE

US7170811035

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:02 2025-12-12 pm EST			Pre-market 05:52:39 am
25.85 ^USD	+0.19%		25.92	+0.29%

Dec. 12	US FDA approves Innoviva's oral antibiotic for gonorrhea	RE
Dec. 12	Pfizer Inc. Declares First-Quarter 2026 Dividend, Payable on March 6, 2026	CI

fbd73e7adf88a806bab.8nTv9BneqrEDOd3AAw860WldBwvJHayVA8FgOuNtJQ8.l0GrkVqHx9J7dLyFVWFigFlrVFKNZOjTSJVQTNQUU13AIKGycLzZ1VUJqg

Published financial data: PFIZER INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	41.91B	81.29B	100B	58.5B	63.63B
Total Revenues	41.91B	81.29B	100B	58.5B	63.63B
Cost of Goods Sold, Total	8.57B	30.66B	34.1B	23.99B	16.42B
Gross Profit	33.33B	50.63B	66.23B	34.51B	47.21B
Selling General & Admin Expenses, Total	10.89B	9.56B	12.2B	13.84B	14.77B
R&D Expenses	8.88B	10.52B	11.43B	10.68B	10.82B
Amortization of Goodwill and Intangible Assets - (IS)	3.44B	3.7B	3.61B	4.73B	5.29B
Other Operating Expenses, Total	23.2B	23.78B	27.24B	29.25B	30.88B
Operating Income	10.13B	26.84B	39B	5.26B	16.33B
Interest Expense, Total	-1.45B	-1.29B	-1.24B	-2.21B	-3.09B
Interest And Investment Income	351M	202M	565M	2.1B	817M
Net Interest Expenses	-1.1B	-1.09B	-673M	-109M	-2.27B
Income (Loss) On Equity Invest.	298M	471M	436M	505M	102M
Currency Exchange Gains (Loss)	-	-192M	-1.15B	164M	50M
Other Non Operating Income (Expenses)	2.29B	1.88B	2.62B	1.28B	-188M
EBT, Excl. Unusual Items	11.62B	27.92B	40.22B	7.09B	14.02B
Restructuring Charges	-859M	-1.36B	-2.02B	-3.33B	-2.64B
Merger & Related Restructuring Charges	-528M	-	-200M	-668M	-1.4B
Gain (Loss) On Sale Of Investments	546M	1.34B	-1.27B	1.59B	1.83B
Gain (Loss) On Sale Of Assets	-237M	99M	-	222M	420M
Asset Writedown	-1.69B	-86M	-421M	-3.02B	-3.3B
In Process R&D Expenses	-	-	-953M	-194M	-108M
Insurance Settlements	-	-	-	-	-
Legal Settlements	-28M	-182M	-230M	-474M	-567M
Other Unusual Items	-1.32B	-3.42B	-394M	-157M	-239M
EBT, Incl. Unusual Items	7.5B	24.31B	34.73B	1.06B	8.02B
Income Tax Expense	477M	1.85B	3.33B	-1.12B	-28M
Earnings From Continuing Operations	7.02B	22.46B	31.4B	2.17B	8.05B
Earnings Of Discontinued Operations	2.63B	-434M	6M	-15M	11M
Net Income to Company	9.65B	22.02B	31.41B	2.16B	8.06B
Minority Interest	-36M	-45M	-35M	-39M	-31M
Net Income - (IS)	9.62B	21.98B	31.37B	2.12B	8.03B
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	9.62B	21.98B	31.37B	2.12B	8.03B
Net Income to Common Excl. Extra Items	6.98B	22.41B	31.37B	2.13B	8.02B
Per Share Items
Net EPS - Basic	1.73	3.92	5.59	0.38	1.42
Basic EPS - Continuing Operations	1.26	4	5.59	0.38	1.42
Basic Weighted Average Shares Outstanding	5.56B	5.6B	5.61B	5.64B	5.66B
Net EPS - Diluted	1.71	3.85	5.47	0.37	1.41
Diluted EPS - Continuing Operations	1.24	3.93	5.47	0.37	1.41
Diluted Weighted Average Shares Outstanding	5.63B	5.71B	5.73B	5.71B	5.7B
Normalized Basic EPS	1.3	3.11	4.48	0.78	1.54
Normalized Diluted EPS	1.28	3.05	4.38	0.77	1.53
Dividend Per Share	1.52	1.56	1.6	1.64	1.68
Payout Ratio	87.77	39.72	28.63	436.38	118.44
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	14.89B	31.95B	44.02B	11.52B	23.32B
EBITA	13.56B	30.54B	42.6B	9.99B	21.61B
EBIT	10.13B	26.84B	39B	5.26B	16.33B
EBITDAR	15.66B	32.84B	45.24B	12.8B	24.5B
Total Revenues (As Reported)	-	-	-	58.5B	63.63B
Effective Tax Rate - (Ratio)	6.36	7.62	9.58	-105.39	-0.35
Current Domestic Taxes	429M	3.38B	2.72B	1.19B	485M
Current Foreign Taxes	1.52B	2.77B	4.37B	1.14B	1.59B
Total Current Taxes	1.95B	6.14B	7.09B	2.33B	2.07B
Deferred Domestic Taxes	-1.18B	-4.34B	-3.58B	-2.79B	-2.2B
Deferred Foreign Taxes	-292M	48M	-183M	-652M	100M
Total Deferred Taxes	-1.47B	-4.29B	-3.76B	-3.44B	-2.1B
Normalized Net Income	7.23B	17.4B	25.11B	4.39B	8.73B
Interest Capitalized	96M	108M	124M	160M	182M
Non-Cash Pension Expense	-76M	-2.14B	-247M	-508M	150M
Supplemental Operating Expense Items
Advertising Expense	1.8B	2B	2.8B	3.7B	3.3B
Selling and Marketing Expenses	1.8B	2B	2.8B	3.7B	3.3B
Research And Development Expense From Footnotes	9.4B	13.83B	11.43B	10.68B	11.17B
Net Rental Expense, Total	773M	888M	1.22B	1.28B	1.18B
Imputed Operating Lease Interest Expense	202M	240M	329M	424M	432M
Imputed Operating Lease Depreciation	571M	648M	889M	859M	745M
Stock-Based Comp., Other (Total)	776M	1.2B	891M	545M	893M
Total Stock-Based Compensation	776M	1.2B	891M	545M	893M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	1.78B	1.94B	416M	2.85B	1.04B
Short Term Investments	10.44B	29.12B	22.32B	9.84B	19.43B
Trading Asset Securities, Total	18M	4M	-	-	-
Total Cash And Short Term Investments	12.24B	31.07B	22.73B	12.69B	20.48B
Accounts Receivable, Total	7.93B	11.48B	10.95B	11.18B	11.46B
Other Receivables	3.26B	4.27B	3.58B	3.98B	3.31B
Total Receivables	11.19B	15.74B	14.53B	15.16B	14.78B
Inventory	8.05B	9.06B	8.98B	10.19B	10.85B
Other Current Assets, Total	3.59B	3.82B	5.02B	5.3B	4.25B
Total Current Assets	35.07B	59.69B	51.26B	43.33B	50.36B
Gross Property Plant And Equipment	30.1B	32.8B	34.45B	37.91B	37.16B
Accumulated Depreciation	-14.81B	-15.07B	-15.17B	-16.04B	-16.48B
Net Property Plant And Equipment	15.29B	17.72B	19.28B	21.86B	20.68B
Long-term Investments	20.38B	21.54B	14.93B	15.38B	2.11B
Goodwill	49.58B	49.21B	51.38B	67.78B	68.53B
Other Intangibles, Total	28.47B	25.15B	43.37B	64.9B	55.41B
Deferred Tax Assets Long-Term	900M	1.6B	4.8B	1.8B	6.6B
Other Long-Term Assets, Total	4.54B	6.57B	12.2B	11.44B	9.71B
Total Assets	154B	181B	197B	227B	213B
Liabilities
Accounts Payable, Total	4.31B	5.58B	6.81B	6.71B	5.63B
Accrued Expenses, Total	6.51B	7.67B	8.32B	9.22B	12B
Short-term Borrowings	701M	605M	385M	8.1B	3.2B
Current Portion of Long-Term Debt	2B	1.64B	2.57B	2.27B	3.78B
Current Portion of Leases	321M	449M	620M	527M	356M
Current Income Taxes Payable	1.05B	1.27B	1.59B	2.35B	2.91B
Unearned Revenue Current, Total	957M	4.02B	2.52B	2.7B	1.51B
Other Current Liabilities	10.07B	21.44B	19.33B	15.92B	13.61B
Total Current Liabilities	25.92B	42.67B	42.14B	47.79B	43B
Long-Term Debt	37.13B	36.2B	33.2B	61.81B	57.8B
Long-Term Leases	1.11B	2.51B	2.6B	2.63B	2.29B
Unearned Revenue Non Current	-	-	-	-	-
Pension & Other Post Retirement Benefits	5.41B	3.72B	2.25B	2.17B	2.12B
Deferred Tax Liability Non Current	4.06B	349M	1.02B	640M	2.12B
Other Non Current Liabilities	17.12B	18.56B	20.08B	22.17B	17.58B
Total Liabilities	90.76B	104B	101B	137B	125B
Preferred Stock Convertible	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	470M	473M	476M	478M	480M
Additional Paid In Capital	88.67B	90.59B	91.8B	92.63B	93.6B
Retained Earnings	96.77B	103B	126B	118B	117B
Treasury Stock	-111B	-111B	-114B	-114B	-115B
Comprehensive Income and Other	-11.69B	-5.9B	-8.3B	-7.96B	-7.84B
Total Common Equity	63.24B	77.2B	95.66B	89.01B	88.2B
Minority Interest	235M	262M	256M	274M	294M
Total Equity	63.47B	77.46B	95.92B	89.29B	88.5B
Total Liabilities And Equity	154B	181B	197B	227B	213B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	5.58B	5.62B	5.62B	5.65B	5.67B
ECS Total Common Shares Outstanding	5.57B	5.62B	5.62B	5.65B	5.67B
Book Value / Share	11.36	13.74	17.03	15.77	15.56
Tangible Book Value	-14.81B	2.85B	916M	-43.67B	-35.74B
Tangible Book Value Per Share	-2.66	0.51	0.16	-7.73	-6.31
Total Debt	41.27B	41.4B	39.38B	75.33B	67.42B
Net Debt	29.03B	10.32B	16.64B	62.64B	46.94B
Debt Equivalent of Unfunded Proj. Benefit Obligation	4.4B	1.73B	1.18B	561M	500M
Debt Equivalent Oper. Leases	6.18B	7.1B	9.74B	10.26B	9.42B
Minority Interest, Total (Incl. Fin. Div)	235M	262M	256M	274M	294M
Equity Method Investments, Total	16.86B	16.47B	11.03B	11.64B	217M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	738M	994M	859M	1.01B	976M
Inventories - Work In Process, Total	4.43B	4.42B	5.52B	5.69B	6.1B
Inventories - Finished Goods, Total	2.88B	3.64B	2.6B	3.5B	3.78B
Land - (BS)	444M	423M	368M	353M	291M
Buildings, Total	9.02B	9B	8.83B	9.05B	9.04B
Machinery, Total	15.69B	16.71B	17.37B	19.66B	20.61B
Full Time Employees	78.5K	79K	83K	88K	81K
Accumulated Allowance for Doubtful Accounts (Supple)	508M	492M	449M	470M	438M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	9.62B	21.98B	31.37B	2.12B	8.03B
Depreciation & Amortization - CF	1.32B	1.4B	1.42B	1.52B	1.71B
Amortization of Goodwill and Intangible Assets - (CF)	3.44B	3.7B	3.61B	4.73B	5.29B
Depreciation & Amortization, Total	4.76B	5.1B	5.03B	6.26B	6.99B
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-6M	-	-	-	-
Asset Writedown & Restructuring Costs	2.07B	363M	586M	3.44B	4.26B
Stock-Based Compensation (CF)	756M	1.18B	872M	525M	877M
Net Cash From Discontinued Operations	3.82B	-343M	-	15M	-11M
Other Operating Activities, Total	-6.33B	-8.51B	-4.14B	-1.48B	-4.34B
Change In Accounts Receivable	-1.25B	-3.81B	261M	347M	-109M
Change In Inventories	-736M	-1.12B	592M	-1.17B	-854M
Change In Accounts Payable	353M	1.24B	1.19B	-300M	-1.02B
Change in Other Net Operating Assets	1.36B	16.5B	-6.5B	-1.05B	-1.08B
Cash from Operations	14.4B	32.58B	29.27B	8.7B	12.74B
Capital Expenditure	-2.25B	-2.71B	-3.24B	-3.91B	-2.91B
Cash Acquisitions	-	-	-23B	-43.43B	-
Sale (Purchase) of Intangible assets	-539M	-	-	-	-
Investment in Marketable and Equity Securities, Total	-1.67B	-19.52B	6.68B	15.24B	5.56B
Other Investing Activities, Total	192M	-318M	3.77B	-180M	0
Cash from Investing	-4.27B	-22.55B	-15.78B	-32.28B	2.65B
Short Term Debt Issued, Total	12.35B	-	3.89B	7.69B	8.91B
Long-Term Debt Issued, Total	5.22B	997M	-	30.83B	-
Total Debt Issued	17.57B	997M	3.89B	38.52B	8.91B
Short Term Debt Repaid, Total	-26.33B	-96M	-4.11B	-3M	-13.82B
Long-Term Debt Repaid, Total	-4B	-2B	-3.3B	-2.57B	-2.25B
Total Debt Repaid	-30.33B	-2.1B	-7.41B	-2.57B	-16.07B
Issuance of Common Stock	425M	-	-	-	-
Repurchase of Common Stock	-	-	-2B	-	-
Common Dividends Paid	-8.44B	-8.73B	-8.98B	-9.25B	-9.51B
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-8.44B	-8.73B	-8.98B	-9.25B	-9.51B
Other Financing Activities, Total	11.12B	16M	-335M	-632M	-469M
Cash from Financing	-9.65B	-9.82B	-14.83B	26.07B	-17.14B
Foreign Exchange Rate Adjustments	-8M	-59M	-165M	-40M	-66M
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	475M	159M	-1.52B	2.45B	-1.81B
Supplemental Items
Cash Interest Paid	1.64B	1.47B	1.44B	2.22B	3.23B
Cash Income Tax Paid (Refund)	3.15B	7.43B	7.87B	3.15B	3.6B
Levered Free Cash Flow	10.5B	30.86B	24.96B	1.02B	12.78B
Unlevered Free Cash Flow	11.41B	31.66B	25.73B	2.4B	14.71B
Change In Net Working Capital	-2.33B	-11.29B	1.32B	3.78B	474M
Net Debt Issued / Repaid	-12.76B	-1.1B	-3.52B	35.94B	-7.16B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	3.93	10	12.87	1.55	4.64
Return on Total Capital	5.71	15.01	19.18	2.19	6.37
Return On Equity %	11.06	31.87	36.22	2.35	9.06
Return on Common Equity	11.06	31.92	36.29	2.31	9.05
Margin Analysis
Gross Profit Margin %	79.54	62.28	66.02	58.99	74.19
SG&A Margin	25.99	11.77	12.16	23.65	23.21
EBITDA Margin %	35.52	39.3	43.88	19.69	36.65
EBITA Margin %	32.37	37.58	42.46	17.08	33.97
EBIT Margin %	24.17	33.02	38.87	8.99	25.66
Income From Continuing Operations Margin %	16.75	27.63	31.3	3.71	12.65
Net Income Margin %	22.95	27.04	31.27	3.62	12.62
Net Avail. For Common Margin %	16.67	27.57	31.26	3.65	12.6
Normalized Net Income Margin	17.24	21.41	25.02	7.51	13.72
Levered Free Cash Flow Margin	25.05	37.96	24.87	1.75	20.08
Unlevered Free Cash Flow Margin	27.22	38.95	25.65	4.11	23.12
Asset Turnover
Asset Turnover	0.26	0.48	0.53	0.28	0.29
Fixed Assets Turnover	2.84	4.95	5.42	2.84	2.99
Receivables Turnover (Average Receivables)	5.7	8.38	8.95	5.29	5.53
Inventory Turnover (Average Inventory)	1.13	3.59	3.78	2.5	1.56
Short Term Liquidity
Current Ratio	1.35	1.4	1.22	0.91	1.17
Quick Ratio	0.9	1.1	0.88	0.58	0.82
Operating Cash Flow to Current Liabilities	0.56	0.76	0.69	0.18	0.3
Days Sales Outstanding (Average Receivables)	64.2	43.54	40.8	69.04	66.23
Days Outstanding Inventory (Average Inventory)	322.59	101.66	96.56	145.84	234.49
Average Days Payable Outstanding	157.02	56.77	66.45	97.92	132.23
Cash Conversion Cycle (Average Days)	229.76	88.42	70.91	116.96	168.49
Long Term Solvency
Total Debt/Equity	65.02	53.44	41.05	84.37	76.18
Total Debt / Total Capital	39.4	34.83	29.1	45.76	43.24
LT Debt/Equity	60.26	49.97	37.33	72.17	67.9
Long-Term Debt / Total Capital	36.51	32.56	26.46	39.14	38.54
Total Liabilities / Total Assets	58.84	57.32	51.36	60.58	58.53
EBIT / Interest Expense	6.99	20.79	31.5	2.38	5.28
EBITDA / Interest Expense	10.81	25.44	36.54	5.79	7.93
(EBITDA - Capex) / Interest Expense	9.25	23.34	33.93	4.03	6.98
Total Debt / EBITDA	2.64	1.26	0.87	5.89	2.75
Net Debt / EBITDA	1.85	0.31	0.37	4.89	1.92
Total Debt / (EBITDA - Capex)	3.08	1.37	0.94	8.47	3.12
Net Debt / (EBITDA - Capex)	2.17	0.34	0.4	7.04	2.17
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	1.79	95.16	23.43	-41.7	6.84
Gross Profit, 1 Yr. Growth %	0.62	52.11	30.89	-47.9	13.03
EBITDA, 1 Yr. Growth %	5.33	123.2	37.21	-73.84	24.22
EBITA, 1 Yr. Growth %	5.64	135	38.87	-76.55	25.3
EBIT, 1 Yr. Growth %	20.89	178.19	44.54	-86.51	30.45
Earnings From Cont. Operations, 1 Yr. Growth %	-35.39	236.9	39.82	-93.08	270.5
Net Income, 1 Yr. Growth %	-40.91	139.97	42.74	-93.25	279
Normalized Net Income, 1 Yr. Growth %	36.68	168.88	42.98	-82.5	5.57
Diluted EPS Before Extra, 1 Yr. Growth %	-35.06	233.05	39.19	-93.24	281.08
Accounts Receivable, 1 Yr. Growth %	17.1	45.06	-4.59	2.05	-0.89
Inventory, 1 Yr. Growth %	13.84	12.96	-0.86	13.45	6.5
Net Property, Plant and Equip., 1 Yr. Growth %	7.26	17.12	8.77	13.43	-5.41
Total Assets, 1 Yr. Growth %	-7.97	17.67	8.67	14.86	-5.79
Tangible Book Value, 1 Yr. Growth %	-22.1	-119.43	-67.83	-4.87K	-18.17
Common Equity, 1 Yr. Growth %	0.18	22.08	23.91	-6.95	-0.91
Cash From Operations, 1 Yr. Growth %	14.42	126.2	-10.17	-70.27	46.48
Capital Expenditures, 1 Yr. Growth %	8.69	21.79	19.37	20.74	-25.54
Levered Free Cash Flow, 1 Yr. Growth %	-24.66	189.11	-19.34	-95.9	129.78
Unlevered Free Cash Flow, 1 Yr. Growth %	-23.55	173.46	-18.95	-90.65	111.91
Dividend Per Share, 1 Yr. Growth %	5.56	2.63	2.56	2.5	2.44
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	1.32	40.97	55.2	-15.17	-20.7
Gross Profit, 2 Yr. CAGR %	2.14	23.75	41.1	-17.42	-16.11
EBITDA, 2 Yr. CAGR %	5.14	51.84	74.52	-40.09	-27.9
EBITA, 2 Yr. CAGR %	5.92	55.88	80.07	-42.93	-29.47
EBIT, 2 Yr. CAGR %	17.35	81.58	99.57	-55.85	-35.98
Earnings From Cont. Operations, 2 Yr. CAGR %	34.85	44.63	117.04	-68.89	-49.36
Net Income, 2 Yr. CAGR %	-7.15	17.11	85.07	-68.95	-49.4
Normalized Net Income, 2 Yr. CAGR %	23.54	82.62	94.92	-50.06	-41.03
Diluted EPS Before Extra, 2 Yr. CAGR %	39.21	44.32	115.3	-69.32	-49.23
Accounts Receivable, 2 Yr. CAGR %	-0.59	30.19	17.65	-1.32	2.31
Inventory, 2 Yr. CAGR %	3.52	13.21	5.82	6.05	9.92
Net Property, Plant and Equip., 2 Yr. CAGR %	6.89	11.48	12.87	11.08	3.58
Total Assets, 2 Yr. CAGR %	-1.64	4.06	13.08	11.72	4.02
Tangible Book Value, 2 Yr. CAGR %	-23.39	-61.3	-75	291.65	524.6
Common Equity, 2 Yr. CAGR %	-0.12	10.59	22.99	7.38	-3.98
Cash From Operations, 2 Yr. CAGR %	-4.6	60.88	42.55	-48.32	-34.01
Capital Expenditures, 2 Yr. CAGR %	6.54	15.11	20.57	20.05	-5.19
Levered Free Cash Flow, 2 Yr. CAGR %	185.26	47.45	52.29	-81.81	-29.19
Unlevered Free Cash Flow, 2 Yr. CAGR %	132.34	44.45	48.51	-72.48	-25.16
Dividend Per Share, 2 Yr. CAGR %	5.72	4.08	2.6	2.53	2.47
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-7.26	25.81	34.86	11.99	-7.84
Gross Profit, 3 Yr. CAGR %	-7.21	16.58	26.07	1.23	-2.29
EBITDA, 3 Yr. CAGR %	-10.68	33.37	47.01	-7.29	-10.09
EBITA, 3 Yr. CAGR %	-11.35	36.19	50.21	-8.72	-11.02
EBIT, 3 Yr. CAGR %	-11.7	53.97	68.56	-18.71	-15.41
Earnings From Cont. Operations, 3 Yr. CAGR %	-30.98	79.84	43.01	-31.18	-28.96
Net Income, 3 Yr. CAGR %	-23.3	25.37	25.09	-38.61	-28.51
Normalized Net Income, 3 Yr. CAGR %	-7.51	54.32	68.81	-12.71	-20.87
Diluted EPS Before Extra, 3 Yr. CAGR %	-29.35	83.13	42.59	-32.06	-28.94
Accounts Receivable, 3 Yr. CAGR %	-1.19	12.67	17.38	12.2	-0.05
Inventory, 3 Yr. CAGR %	2.02	6.46	8.31	8.31	6.2
Net Property, Plant and Equip., 3 Yr. CAGR %	3.32	9.81	10.57	13.05	5.29
Total Assets, 3 Yr. CAGR %	-3.53	4.41	5.57	13.67	5.55
Tangible Book Value, 3 Yr. CAGR %	-23.75	-51.68	-63.61	43.9	132.4
Common Equity, 3 Yr. CAGR %	-3.91	6.79	14.86	12.07	4.54
Cash From Operations, 3 Yr. CAGR %	-5.01	27.21	32.48	-15.47	-26.87
Capital Expenditures, 3 Yr. CAGR %	4.81	10.97	16.51	20.63	2.38
Levered Free Cash Flow, 3 Yr. CAGR %	-7.55	188.1	20.7	-54.34	-25.53
Unlevered Free Cash Flow, 3 Yr. CAGR %	-6.78	146.54	19.25	-40.93	-22.62
Dividend Per Share, 3 Yr. CAGR %	5.9	4.68	3.57	2.57	2.5
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-3.02	9	13.81	7.46	9.24
Gross Profit, 5 Yr. CAGR %	-3.33	4.36	9.68	1.55	7.39
EBITDA, 5 Yr. CAGR %	-4.59	10.21	16.08	-3.08	10.97
EBITA, 5 Yr. CAGR %	-4.99	10.97	16.96	-3.74	11.45
EBIT, 5 Yr. CAGR %	-5.99	13.75	21.53	-6.49	14.93
Earnings From Cont. Operations, 5 Yr. CAGR %	0.13	25.44	8.02	-10.86	-5.6
Net Income, 5 Yr. CAGR %	6.68	24.96	8.04	-28.26	-12.91
Normalized Net Income, 5 Yr. CAGR %	-5.07	13.75	22.41	-1.48	10.84
Diluted EPS Before Extra, 5 Yr. CAGR %	2.23	27.42	9.24	-10.38	-5.66
Accounts Receivable, 5 Yr. CAGR %	-0.61	6.89	5.9	6.85	11.1
Inventory, 5 Yr. CAGR %	1.38	5.96	3.46	6.3	8.95
Net Property, Plant and Equip., 5 Yr. CAGR %	2.13	5.88	6.81	10.31	7.72
Total Assets, 5 Yr. CAGR %	-1.62	1.12	2.8	7.28	4.95
Tangible Book Value, 5 Yr. CAGR %	-9.13	-43.06	-51.29	11.59	13.45
Common Equity, 5 Yr. CAGR %	-0.45	5.34	6.06	7.03	6.92
Cash From Operations, 5 Yr. CAGR %	-0.39	15.01	11.74	-11.28	0.25
Capital Expenditures, 5 Yr. CAGR %	10.02	8.26	10.59	14.51	7.29
Levered Free Cash Flow, 5 Yr. CAGR %	-5.32	18.96	13.44	-4.51	-2.08
Unlevered Free Cash Flow, 5 Yr. CAGR %	-4.75	18.25	12.82	2.62	-0.62
Dividend Per Share, 5 Yr. CAGR %	6.3	5.39	4.56	3.82	3.13